Page 161 - CW E-Magazine (6-5-2025)
P. 161

News from Abroad


       RESTRUCTURING

       TotalEnergies to stop operating Antwerp steam

       cracker by end-2027

          French oil major TotalEnergies will
       shut its oldest steam cracker in Antwerp
       by end-2027, the company said, citing a
       “significant surplus of ethylene expec-
       ted in Europe.” The unit shutdown will
       not result in layoffs, but 253 employees
       will be offered a retirement package or
       an internal transfer.

          TotalEnergies said the cracker to
       be shut, historically produced most of
       its ethylene for one major client, who
       declined  to  renew  a  contract  expiring
       in 2027. As a result, the steam cracker,  industrial  units in  Antwerp and   and Covestro announced a permanent
       which is  not integrated to  TotalEner-  Feluy,” the company said. The chemical  shutdown of some production units in
       gies’ downstream polymer production,  industry has been grappling with weak  the Netherlands.
       will no longer have any outlets for its  demand and high input costs in Europe
       ethylene production.              in recent years, prompting several firms   The Antwerp site is already undergo-
                                         to close or convert units. ExxonMobil  ing changes to begin producing sustaina-
          “The unit shutdown will allow the  Chemical France moved to  close its  ble aviation fuels this year, with plans to
       site to focus on its more recent steam  steam cracker and petrochemical  pro-  use green hydrogen made from Total’s
       cracker, whose  ethylene production is  duction at Port Jerome in the country’s  offshore  wind  farms  to  make  more
       entirely consumed by  TotalEnergies’   north last year, while LyondellBasell  renewable transport fuels by 2027.

       Carbogen Amcis’ Shanghai site gets drug manu-


       facturing license in China
          Carbogen  Amcis, a Switzerland-
       based  pharmaceutical process  deve-
       lopment and  Active Pharmaceutical
       Ingredient  (API)  manufacturing  com-
       pany  and  part  of  Ahmedabad-based
       Dishman group, has announced that its
       Shanghai facility has obtained its first
       Drug  Manufacturing  License  (DML)
       from  China’s  National  Medical  Pro-
       ducts Administration (NMPA).      strength  of  its  quality  systems,  the   and  commercial  GMP  manufacture.
                                         company said.                    Its  services  range  from  raw  materials
          The  NMPA  approval  followed                                   to APIs, including high potency mate-
       a  rigorous  review  focused  on  GMP   Located in the Shanghai Chemical  rial handling and micronisation.  With
       compliance and operational readiness.  Industry Park (SCIP), the  40,000-m²  equipment  in  four  segregated  units
       The Shanghai site successfully met all  site  is  a  fully  self-supporting  facility  and reactor capacities from 50 to 6,300
       regulatory  expectations,  reflecting  the   equipped for early-phase research and  litres, the facility is built for flexibility,
       maturing  of  its  operations  and  the  development, pilot scale production  efficiency and scalability.


       Chemical Weekly  May 6, 2025                                                                    161


                                      Contents    Index to Advertisers    Index to Products Advertised
   156   157   158   159   160   161   162   163   164   165   166